Angiogenic activity and IL-12p40 concentration in healthy people and diabetes patients sera

Central-European Journal of Immunology

Volumn 31, Issue 1-2, 2006, Pages 18-21

  Skopiński, Piotr ^a,b   Barcz, Ewa ^b   Szaflik, Jerzy ^b   Lipińska, Anna ^c   Sommer, Ewa ^b   Demkow, Urszula ^b,d   Skopińska Rózewska, Ewa ^b  

^a Department of Histology and Embryology   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c Department of Internal Medicine Faculty of Dentistry

^d NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

Author keywords

Angiogenesis; Diabetes mellitus; IL 12p40

Indexed keywords

INTERLEUKIN 12P40;

ADULT; AGED; ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RETINOPATHY; SERUM;

EID: 33750414351     PISSN: 14263912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Trinchieri G (2003): Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3: 133-146.
2. Wigginton JM, Wiltrout RH (2002): IL-12/IL-2 combination cytokine therapy for solid tumours: translation from bench to bedside. Expert Opin Biol Ther 2: 513-524.
3. Voest EE, Kenyon BM, O'Reilly MS, et al. (1995): Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst 87: 581-586.
4. Sidky YA, Auerbach R (1975): Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs-host reaction. J Exp Med 5: 1084-1100.
5. Barcz E, Skopińska-Różewska E, Kamiński P, et al. (2002): Angiogenic activity and IL-8 concentration in peritoneal fluid and sera in endometriosis. Int J Gynaecol Obstet 79: 229-235.
6. Skopiński P, Rogala E, Duda-Król B, et al. (2005): Increased interleukin-18 content and angiogenic activity of sera from diabetic (Type 2) patients with background retinopathy. J Diabetes Complications 19: 335-338.
7. Chorostowska-Wynimko J, Skopinski P, Szaflik J, et al. (2005): In vitro angiomodulatory activity of sera from type 2 diabetic patients with background retinopathy. J Physiol Pharmacol 56: 65-70.
8. Skopinski P, Duda-Krol B, Lipinska A, et al. (2004): Angiogenic activity and VEGF level in sera of diabetic patients with non-proliferative retinopathy. Klin Oczna 106: 421-423.
9. Abdi K (2002): IL-12: the role of p40 versus p75. Scand J Immunol 56: 1-11.
10. Skopinski P, Duda-Krol B, Lipinska A, et al. (2004): Proteinases inhibitors in sera of diabetic patients with non-proliferative retinopathy. Klin Oczna 106: 424-6.